About Biocon Biocon's Products & Services Research & Development Biocon's Technology Investors Media Careers CSR
Biocon-Media
  > MEDIA
  Overview
  Press Releases
  Media Stories
  Download Center
  Video Gallery
  Photo Gallery
  Media Contacts
  
  
     
 

Press Releases

2017
2016 2015 2014 2013 2012 2011
2010 2009 2008 2007 2006 2005

 
  July 2017
14 Jul FDA Oncologic Drugs Advisory Committee Unanimously Recommends Approval of Mylan and Biocon’s Proposed Biosimilar Trastuzumab Download Pdf
09 Jul Biocon Statement on ANSM Inspection Report Download Pdf
  June 2017
11 Jun Mylan and Biocon Present Clinical Data on Insulin Glargine at the American Diabetes Association's 77th Scientific Sessions Download Pdf
05 Jun Biocon Appoints Ms. Pratima Rao as Mission Director of Biocon Foundation Download Pdf
  May 2017
10 May Company Statement on Media Reports on USFDA 483s Download Pdf
05 May Kiran Mazumdar-Shaw Felicitated with 'AWSM Award for Excellence 2017' by The Feinstein Institute for Medical Research, USA Download Pdf
  April 2017
27 Apr  Biocon Q4 FY17 Revenue Rs 974 Cr; Net  Profit Rs 127 Cr; FY17 Revenue at Rs 4,079  Cr; Net Profit at Rs 612 Cr Download Pdf
  February 2017
16 Feb  U.S. FDA Accepts Biologics License  Application (BLA) for Mylan and Biocon's  Proposed Biosimilar Pegfilgrastim for Review Download Pdf
07 Feb  Biocon Foundation & Department of Medical,  Health & Family Welfare, Govt. of Karnataka  Collaborate to Set Up Smart eLAJ Clinics in  Karnataka Download Pdf
  January 2017
25 Jan  Biocon Wins MYR 300 Million Contract for  Insulin from MoH, Malaysia Download Pdf
24 Jan  Biocon Q3 FY17 Net Profit Up 65% at Rs 171  Crore Revenue Rises 32% at Rs 1092  Crore; EBITDA Increases 57% to Rs 324  Crore Download Pdf
11 Jan  U.S. FDA Accepts Biologics License  Application (BLA) for Mylan and Biocon's  Proposed Biosimilar Trastuzumab Download Pdf
 
 
 
 
 
     
  Biocon

Businesses

Recommended sites Biocon on  
  Home
About Us

Investor Relations
Media Relations
Careers
Site Map
Contact Us
Our Growth Accelerators
Fact Sheet
Branded Formulations
Biopharmaceuticals
Research Services
Active Discovery Program

ABLE
Karnataka Vision Group on BT
Syngene International
Biocon Academy

    Linked In   
       
  Report adverse event/side effects and product complaints    
       
  * Disclaimer            © 2016, Biocon. All Rights Reserved